BioSpace News Archive

Business

Amgen Downsizes by 300 Amid Industry Constriction

Amgen is implementing organizational changes including laying off approximately 300 team members, confirmed Monday.

January 30, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Vera Doubles Down on IgAN Data with 36-Week Analysis (Updated)

Vera Therapeutics released a 36-week per-protocol analysis of the Phase IIb trial assessing atacicept in IgA nephropathy.

January 30, 2023
·
2 min read
·
Kate Goodwin
Business

What Will it Take for AI to Live Up to its Hype?

The pharmaceutical industry is expected to spend more than $3 billion on artificial intelligence by 2025, but advocates say it is not yet living up to its potential.

January 30, 2023
·
4 min read
·
Gail Dutton
Career Advice

The Top Programming Languages to Learn in the Life Sciences

Computer programming jobs in biopharma are on the rise, but candidates must have a specific skill set. To help, here are the best programming languages for those working in the life sciences.

January 30, 2023
·
6 min read
·
Hayley Shasteen
Drug Development

Phase III Trial Fails to Confirm Efficacy of Novartis’ SCD Therapeutic

Novartis’ SCD therapeutic Adakveo is under review by the EMA after failing to replicate previous efficacy results in a Phase III trial.

January 30, 2023
·
1 min read
·
Hayley Shasteen
Colossal Closes $150M Series B with Eye on the Iconic Dodo

Tuesday, de-extinction company Colossal Biosciences closed a mammoth, $150 million Series B financing round and announced plans to resurrect the iconic Dodo – extinct since the 17th century.

January 30, 2023
·
3 min read
·
Heather McKenzie
Drug Development

FDA Approves First Reversible BTK Inhibitor

The FDA granted Eli Lilly’s Jaypirca accelerated approval for the treatment of adults with relapsed or refractory mantle cell lymphoma.

January 30, 2023
·
2 min read
·
Tristan Manalac
Business

Remote Work, Consolidation Potential Detractors for Boston

At a panel Friday, “Boston’s Booming Biotech System,” experts from industry and academia weighed in on the financial repercussions of 2022 and what it portends for 2023.

January 30, 2023
·
3 min read
·
Lisa Munger
Business

James A. Reeves, Jr., MD, Clinical Research Leader, to Retire From Florida Cancer Specialists & Research Institute

Florida Cancer Specialists & Research Institute, LLC announces that James A. Reeves Jr, MD will retire from its Research Division, effective January 31, 2023.

January 30, 2023
·
3 min read
Business

Pharma-Bio Serv Announces Full Year Results

Pharma-Bio Serv, Inc. (“Pharma-Bio Serv” or the “Company”) (OTCQB:PBSV), is a regulatory, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries.

January 30, 2023
·
2 min read